Research and Markets: Rheumatoid Arthritis Therapeutics Pipeline Review, H2 2014 - Analysis Drug Profiles from 220+ Companies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/45r6bs/rheumatoid) has announced the addition of the "Rheumatoid Arthritis - Pipeline Review, H2 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Rheumatoid Arthritis Overview
  3. Therapeutics Development
  4. Rheumatoid Arthritis - Therapeutics under Development by Companies
  5. Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes
  6. Rheumatoid Arthritis - Pipeline Products Glance
  7. Rheumatoid Arthritis - Products under Development by Companies
  8. Rheumatoid Arthritis - Products under Investigation by Universities/Institutes
  9. Rheumatoid Arthritis - Companies Involved in Therapeutics Development
  10. Rheumatoid Arthritis - Therapeutics Assessment
  11. Drug Profiles
  12. Rheumatoid Arthritis - Recent Pipeline Updates
  13. Rheumatoid Arthritis - Dormant Projects
  14. Rheumatoid Arthritis - Discontinued Products
  15. Rheumatoid Arthritis - Product Development Milestones
  16. Appendix

For more information visit http://www.researchandmarkets.com/research/45r6bs/rheumatoid

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders